Volibo (Voglibose) 0.2mg – 100 tablet

USD $43.65

Each Volibo contains .2mg Voglibose 100 tablets and is used to lower blood glucose level in patients with Type 2 Diabetes Mellitus

ATC Classification: A10BF03
Active Ingrediant: Voglibose
Generic Name: Volibo
Manufacturer: Sun Pharma
Strength: 0.2mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 TABLET

Important update for customers in the USA:

The World has stopped all packages mailing to the USA due to De Minimus Exemption.

  1. This situation is real and affects the world, not just India. See your local news or this Fox Business report .
  2. We got through COVID; we will get through this as well.
  3. By law we must temporarily remove Card and eCheck for USA shipments because we cannot mail today.
  4. Suggestion: order now to hold your place — shipping will be first-come, first-served once mailing resumes (mail is already queued).
  5. Waiting to place your order is fine; we expect resolution soon, but mail is piling up worldwide, not only with our firm.
  6. We ship normally to the UK, AUS, Japan, and most others. The hold is on the USA side only.
Thanks for your patience.
Examples of Packages sent

 

Product Availability (US)

Not available in US

 

Storage/Stability

Store at room temperature. Protect from moisture.

 

Adverse Reactions

Frequency not always defined.

Cardiovascular: Facial edema (<5%)

Central nervous system: Burning sensation (<5%), malaise (<5%), numbness (<5%)

Dermatologic: Alopecia (<5%)

Endocrine & metabolic: Changes in LDH (<5%, increased), decreased HDL cholesterol (<5%), hyperkalemia (<5%), increased alpha-1-antitrypsin (<5%), increased gamma-glutamyl transferase (<5%), hyperammonemia

Gastrointestinal: Abdominal distention (<5%), abdominal pain (<5%), anorexia (<5%), constipation (<5%), diarrhea (<5%), dyspepsia (<5%), flatulence (<5%), heartburn (<5%), increased serum amylase (<5%), loose stools (<5%), nausea (<5%), vomiting (<5%), intestinal obstruction

Hematologic & oncologic: Anemia (<5%)

Hepatic: Increased serum ALT (<5%), increased serum AST (<5%), hepatitis (acute)

Neuromuscular & skeletal: Weakness (<5%)

Ophthalmic: Decreased visual acuity (<5%)

Miscellaneous: Fever (<5%)

<1%, postmarketing, and/or case reports: Delayed gastric emptying, dizziness, drowsiness, dysgeusia, gastritis, headache, hypoglycemia, jaundice, photophobia, pneumatosis cystoides intestinalis, polydipsia, pruritus, severe hepatic insufficiency, skin rash, staggering, stomatitis, thrombocytopenia, tongue ulcer

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Brand

Sun Pharma

Reviews

There are no reviews yet

Be the first to review “Volibo (Voglibose) 0.2mg – 100 tablet”

Your email address will not be published. Required fields are marked *